We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Van Baar and colleagues’ study comprised 16 patients ...
HealthDay News — Single-procedure duodenal mucosal resurfacing (DMR) is effective for reducing glycated hemoglobin (HbA1c) in patients with type 2 diabetes, according to a study published online in ...
LEXINGTON, Mass.-- (BUSINESS WIRE)--Fractyl Laboratories Inc. (Fractyl) today announced clinical data that elucidate the mechanisms behind the beneficial effects and significant improvements in ...
Improving metabolic disorders without major changes in diet and exercise is typically seen as impossible, unless bariatric surgery is involved. But that’s precisely what Fractyl Laboratories Inc. aims ...
The FDA has granted breakthrough device designation to Fractyl Laboratories Inc. for Revita DMR, a duodenal mucosal resurfacing treatment for patients with type 2 diabetes. The company recently ...
NICE did a rapid review of the published literature on the efficacy and safety of this procedure. This comprised a comprehensive literature search and detailed review of the evidence from 5 sources, ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Fractyl Laboratories Inc. (Fractyl), a life sciences company dedicated to novel therapeutic interventions that can reverse the metabolic disease epidemic, today ...
Type 2 diabetes is a chronic, progressive metabolic condition characterised by insulin resistance and insufficient pancreatic insulin production, resulting in hyperglycaemia. The condition is commonly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results